1. Amgen Inc.
2. AstraZeneca PLC
3. Bristol Myers Squibb and Company
4. Cipla Limited
5. Eli Lilly and Company
6. Merck KGaA
7. Sanofi S.A.
8. Texas Oncology
| Published | Pages | Publisher | Report code |
|---|---|---|---|
| Jan 2024 | 182 | 360 iResearch | ASDR-650156 |
1. Amgen Inc.
2. AstraZeneca PLC
3. Bristol Myers Squibb and Company
4. Cipla Limited
5. Eli Lilly and Company
6. Merck KGaA
7. Sanofi S.A.
8. Texas Oncology
Published: May, 2025 | Report code: ASDR-676311
US $
Euro €
GBP £